Cytoskeletal inhibitors induce protoplast formation and morphotype changes

Treatment with cytoskeletal inhibitors (e.g., myosin or Arp2/3 complex drugs) causes protoplast formation and affects cellular morphotypes, indicating cytoskeletal regulation of cell shape transitions.

Part of Chain